Join
Live feed
·
INSIDERFilingvia Quantisnow
Vir Biotechnology Inc. logo

EVP and General Counsel De Verneuil Vanina was granted 35,000 units of Common Stock and sold $48,590 worth of Common Stock (5,140 units at $9.45), increasing direct ownership by 52% to 86,833 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VIR (Vir Biotechnology Inc.) and more on Quantisnow.